Cara Therapeutics, Inc. (NASDAQ:CARA) Short Interest Up 9.7% in October

Cara Therapeutics, Inc. (NASDAQ:CARA – Get Free Report) was the recipient of a significant growth in short interest in October. As of October 15th, there was short interest totalling 2,710,000 shares, a growth of 9.7% from the September 30th total of 2,470,000 shares. Approximately 6.0% of the company’s shares are sold short. Based on an […]

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,United States ,Piper Sandler ,Stifel Nicolaus ,Envestnet Asset Management Inc ,Cambridge Investment Research Advisors Inc ,Nasdaq ,York Mellon Corp ,Cara Therapeutics Inc ,Needham Company ,Citigroup Inc ,Cara Therapeutics ,Get Free Report ,Asset Management ,New York Mellon Corp ,Investment Research Advisors ,Cara Therapeutics Daily ,Nasdaq Cara ,Cara ,Medical ,Stocks ,Options ,Put ,Call ,